Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
Ylin-
Alin-
Vaihto-
2025 Q4 -tulosraportti

Vain PDF

12 päivää sitten

Tarjoustasot

DenmarkFirst North Denmark
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
5 000--
5 000--
767--
9 312--
20 000--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi225 697225 69700

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi225 697225 69700

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
30.4.
Menneet tapahtumat
2025 Q4 -tulosraportti
26.2.
2025 Q3 -tulosraportti
22.10.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025
2024 Q4 -tulosraportti
27.2.2025

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 9 t sitten
    ·
    9 t sitten
    ·
    Does anyone know who the seller is of the 500 thousand that are out now?
    3 t sitten
    ·
    3 t sitten
    ·
    I can clearly see that I read it as the devil reads the bible. Sorry.
  • 10 t sitten
    ·
    10 t sitten
    ·
    As expected, Q4 was no boost for Stenocare. For that, the report was too weak overall. The share price is pointing downwards, and technically, the support around 1.3 is also broken. That makes the way back up a bit harder as we now meet resistance there. Unless we get some positive fundamental news, I don't foresee any rise in the near future. And then there was the financing need. Money must be in place soon one way or another. I probably won't buy more Stenocare until I know how the company will solve it.
    9 t sitten
    ·
    9 t sitten
    ·
    I think they increase their revenue with the measures they have taken and thereby also more cash flow On days before news and financial reports, the stock is sometimes traded higher, which can be incomprehensible So news or not Apparently, it only takes a little bad publicity for people to panic and sell If the price starts to gain momentum, they jump on the bandwagon and buy without news 🤔 I myself have bought in several rounds And I'm happy to wait Stocks can go both ways, and one must be aware that loss and patience must be accepted
    8 t sitten
    ·
    8 t sitten
    ·
    I naturally agree with you that one must be patient if one is to succeed in the stock market, and it's far from always going up. I still have my shares in the company intact as I still haven't lost faith that this will eventually work out. But the path upwards might seem a bit tougher than I thought when I made my first purchase. I will probably wait for a couple more reports before I eventually sell out.
  • 10 t sitten
    ·
    10 t sitten
    ·
    It's been a couple of days since I claimed that doctors in Germany are concerned that the medical cannabis oils do not meet standardization strengths across all batches. I made this claim from memory, so I didn't include a link. So when Stenocare's management claims that the agreement with Weeco in Germany will be valuable for Stenocare, because Astrum 10-10 is the only product on the market that meets the doctors' conditions for prescribing medical oil. That the product must have the same strengths across all batches. Then I believe that is correct. To you who claimed that only doctors from Denmark are concerned about the above. This is the latest article I could find on the subject from Germany. Urgent call for standardizing medical cannabis extracts: Meeting patients' needs https://krautinvest.de/urgent-call-for-standardizing-medical-cannabis-extracts-meeting-patients-needs/
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Since my post about Cantourage Group SE on December 12, 2025, the stock has now risen by more than 65%. I continue to follow the case closely and can only recommend taking a closer look if one desires exposure to cannabis in Europe – especially if one is looking for quality stocks. 😉 This morning's conference call seems to have further supported the positive development, and the latest M&A activity in the German industry is now also starting to resonate with Cantourage - albeit with a certain time delay.
    10 t sitten
    ·
    10 t sitten
    ·
    Cool thanks! Do you have a place where I can follow your movements? :) I myself am a supporter of Blueocean, and I think you express yourself well.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Sorry, I should of course have included a link. blueoceanguy according to the link below, the Sclerosis Association has also researched whether worries can be the reason people use more medicine. Here are the most important points from the research: Cortisol response: When you worry about e.g. war, the brain activates the body's stress response. This releases the hormone cortisol. While cortisol is beneficial in the short term, a chronically high level can "shut down" vital parts of the immune system. Weakened defense: Long-term worry reduces the number of white blood cells (especially T-cells and NK-cells), which are the body's primary defense against viruses and bacteria. You therefore become more susceptible to infections. Inflammation: Chronic worry can paradoxically also lead to the immune system becoming overactive in an inappropriate way, which creates chronic inflammation in the body. In short: Your body cannot tell the difference between a physical threat and the mental threat you experience through the news. Both drain the resources the immune system needs to keep you healthy. https://www.navimol.de/da/blogs/leben-mit-ms/psychoneuroimmunologie-wie-gefuehle-das-immunsystem-beeinflussen
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    3D, Just worries about constantly falling stock prices in your two favorite companies, bioporto and stenocare, don't end up sending you to cannabis medicine.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q4 -tulosraportti

Vain PDF

12 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 9 t sitten
    ·
    9 t sitten
    ·
    Does anyone know who the seller is of the 500 thousand that are out now?
    3 t sitten
    ·
    3 t sitten
    ·
    I can clearly see that I read it as the devil reads the bible. Sorry.
  • 10 t sitten
    ·
    10 t sitten
    ·
    As expected, Q4 was no boost for Stenocare. For that, the report was too weak overall. The share price is pointing downwards, and technically, the support around 1.3 is also broken. That makes the way back up a bit harder as we now meet resistance there. Unless we get some positive fundamental news, I don't foresee any rise in the near future. And then there was the financing need. Money must be in place soon one way or another. I probably won't buy more Stenocare until I know how the company will solve it.
    9 t sitten
    ·
    9 t sitten
    ·
    I think they increase their revenue with the measures they have taken and thereby also more cash flow On days before news and financial reports, the stock is sometimes traded higher, which can be incomprehensible So news or not Apparently, it only takes a little bad publicity for people to panic and sell If the price starts to gain momentum, they jump on the bandwagon and buy without news 🤔 I myself have bought in several rounds And I'm happy to wait Stocks can go both ways, and one must be aware that loss and patience must be accepted
    8 t sitten
    ·
    8 t sitten
    ·
    I naturally agree with you that one must be patient if one is to succeed in the stock market, and it's far from always going up. I still have my shares in the company intact as I still haven't lost faith that this will eventually work out. But the path upwards might seem a bit tougher than I thought when I made my first purchase. I will probably wait for a couple more reports before I eventually sell out.
  • 10 t sitten
    ·
    10 t sitten
    ·
    It's been a couple of days since I claimed that doctors in Germany are concerned that the medical cannabis oils do not meet standardization strengths across all batches. I made this claim from memory, so I didn't include a link. So when Stenocare's management claims that the agreement with Weeco in Germany will be valuable for Stenocare, because Astrum 10-10 is the only product on the market that meets the doctors' conditions for prescribing medical oil. That the product must have the same strengths across all batches. Then I believe that is correct. To you who claimed that only doctors from Denmark are concerned about the above. This is the latest article I could find on the subject from Germany. Urgent call for standardizing medical cannabis extracts: Meeting patients' needs https://krautinvest.de/urgent-call-for-standardizing-medical-cannabis-extracts-meeting-patients-needs/
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Since my post about Cantourage Group SE on December 12, 2025, the stock has now risen by more than 65%. I continue to follow the case closely and can only recommend taking a closer look if one desires exposure to cannabis in Europe – especially if one is looking for quality stocks. 😉 This morning's conference call seems to have further supported the positive development, and the latest M&A activity in the German industry is now also starting to resonate with Cantourage - albeit with a certain time delay.
    10 t sitten
    ·
    10 t sitten
    ·
    Cool thanks! Do you have a place where I can follow your movements? :) I myself am a supporter of Blueocean, and I think you express yourself well.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Sorry, I should of course have included a link. blueoceanguy according to the link below, the Sclerosis Association has also researched whether worries can be the reason people use more medicine. Here are the most important points from the research: Cortisol response: When you worry about e.g. war, the brain activates the body's stress response. This releases the hormone cortisol. While cortisol is beneficial in the short term, a chronically high level can "shut down" vital parts of the immune system. Weakened defense: Long-term worry reduces the number of white blood cells (especially T-cells and NK-cells), which are the body's primary defense against viruses and bacteria. You therefore become more susceptible to infections. Inflammation: Chronic worry can paradoxically also lead to the immune system becoming overactive in an inappropriate way, which creates chronic inflammation in the body. In short: Your body cannot tell the difference between a physical threat and the mental threat you experience through the news. Both drain the resources the immune system needs to keep you healthy. https://www.navimol.de/da/blogs/leben-mit-ms/psychoneuroimmunologie-wie-gefuehle-das-immunsystem-beeinflussen
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    3D, Just worries about constantly falling stock prices in your two favorite companies, bioporto and stenocare, don't end up sending you to cannabis medicine.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkFirst North Denmark
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
5 000--
5 000--
767--
9 312--
20 000--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi225 697225 69700

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi225 697225 69700

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
30.4.
Menneet tapahtumat
2025 Q4 -tulosraportti
26.2.
2025 Q3 -tulosraportti
22.10.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025
2024 Q4 -tulosraportti
27.2.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q4 -tulosraportti

Vain PDF

12 päivää sitten

Uutiset

AI
Viimeisin
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2026 Q1 -tulosraportti
30.4.
Menneet tapahtumat
2025 Q4 -tulosraportti
26.2.
2025 Q3 -tulosraportti
22.10.2025
2025 Q2 -tulosraportti
21.8.2025
2025 Q1 -tulosraportti
8.5.2025
2024 Q4 -tulosraportti
27.2.2025

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 9 t sitten
    ·
    9 t sitten
    ·
    Does anyone know who the seller is of the 500 thousand that are out now?
    3 t sitten
    ·
    3 t sitten
    ·
    I can clearly see that I read it as the devil reads the bible. Sorry.
  • 10 t sitten
    ·
    10 t sitten
    ·
    As expected, Q4 was no boost for Stenocare. For that, the report was too weak overall. The share price is pointing downwards, and technically, the support around 1.3 is also broken. That makes the way back up a bit harder as we now meet resistance there. Unless we get some positive fundamental news, I don't foresee any rise in the near future. And then there was the financing need. Money must be in place soon one way or another. I probably won't buy more Stenocare until I know how the company will solve it.
    9 t sitten
    ·
    9 t sitten
    ·
    I think they increase their revenue with the measures they have taken and thereby also more cash flow On days before news and financial reports, the stock is sometimes traded higher, which can be incomprehensible So news or not Apparently, it only takes a little bad publicity for people to panic and sell If the price starts to gain momentum, they jump on the bandwagon and buy without news 🤔 I myself have bought in several rounds And I'm happy to wait Stocks can go both ways, and one must be aware that loss and patience must be accepted
    8 t sitten
    ·
    8 t sitten
    ·
    I naturally agree with you that one must be patient if one is to succeed in the stock market, and it's far from always going up. I still have my shares in the company intact as I still haven't lost faith that this will eventually work out. But the path upwards might seem a bit tougher than I thought when I made my first purchase. I will probably wait for a couple more reports before I eventually sell out.
  • 10 t sitten
    ·
    10 t sitten
    ·
    It's been a couple of days since I claimed that doctors in Germany are concerned that the medical cannabis oils do not meet standardization strengths across all batches. I made this claim from memory, so I didn't include a link. So when Stenocare's management claims that the agreement with Weeco in Germany will be valuable for Stenocare, because Astrum 10-10 is the only product on the market that meets the doctors' conditions for prescribing medical oil. That the product must have the same strengths across all batches. Then I believe that is correct. To you who claimed that only doctors from Denmark are concerned about the above. This is the latest article I could find on the subject from Germany. Urgent call for standardizing medical cannabis extracts: Meeting patients' needs https://krautinvest.de/urgent-call-for-standardizing-medical-cannabis-extracts-meeting-patients-needs/
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Since my post about Cantourage Group SE on December 12, 2025, the stock has now risen by more than 65%. I continue to follow the case closely and can only recommend taking a closer look if one desires exposure to cannabis in Europe – especially if one is looking for quality stocks. 😉 This morning's conference call seems to have further supported the positive development, and the latest M&A activity in the German industry is now also starting to resonate with Cantourage - albeit with a certain time delay.
    10 t sitten
    ·
    10 t sitten
    ·
    Cool thanks! Do you have a place where I can follow your movements? :) I myself am a supporter of Blueocean, and I think you express yourself well.
  • 1 päivä sitten
    ·
    1 päivä sitten
    ·
    Sorry, I should of course have included a link. blueoceanguy according to the link below, the Sclerosis Association has also researched whether worries can be the reason people use more medicine. Here are the most important points from the research: Cortisol response: When you worry about e.g. war, the brain activates the body's stress response. This releases the hormone cortisol. While cortisol is beneficial in the short term, a chronically high level can "shut down" vital parts of the immune system. Weakened defense: Long-term worry reduces the number of white blood cells (especially T-cells and NK-cells), which are the body's primary defense against viruses and bacteria. You therefore become more susceptible to infections. Inflammation: Chronic worry can paradoxically also lead to the immune system becoming overactive in an inappropriate way, which creates chronic inflammation in the body. In short: Your body cannot tell the difference between a physical threat and the mental threat you experience through the news. Both drain the resources the immune system needs to keep you healthy. https://www.navimol.de/da/blogs/leben-mit-ms/psychoneuroimmunologie-wie-gefuehle-das-immunsystem-beeinflussen
    1 päivä sitten
    ·
    1 päivä sitten
    ·
    3D, Just worries about constantly falling stock prices in your two favorite companies, bioporto and stenocare, don't end up sending you to cannabis medicine.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkFirst North Denmark
Määrä
Osto
-
Myynti
Määrä
-

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
5 000--
5 000--
767--
9 312--
20 000--

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Ostaneet eniten

Ostaneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi225 697225 69700

Myyneet eniten

Myyneet eniten
VälittäjäOstettuMyytyNettoSisäinen
Anonyymi225 697225 69700
© 2026 Nordnet Bank AB.
Nordnet | Alvar Aallon katu 5 C, 3. krs | FI-00100 Helsinki